| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MTO1_0000800 | Exon-Exon | chr6:74175932-74191967 | chr6:73466209-73482244 | 205 nt | 0.5366 |
| hsa_MTO1_0001000 | Exon-Exon | chr6:74175932-74202075 | chr6:73466209-73492352 | 119 nt | 0.4202 |
| hsa_MTO1_0001100 | Exon-Exon | chr6:74175932-74207619 | chr6:73466209-73497896 | 1820 nt | 0.4577 |
| hsa_chr6_0619200 | Intergenic-Intergenic | chr6:74176073-74189563 | chr6:73466350-73479840 | 576 nt | 0.4462 |
| hsa_MTO1_0001200 | Exon-Exon | chr6:74176212-74189567 | chr6:73466489-73479844 | 231 nt | 0.4459 |
| hsa_MTO1_0001300 | Exon-Exon | chr6:74176212-74202075 | chr6:73466489-73492352 | 1459 nt | 0.4626 |
| hsa_MTO1_0001400 | Exon-Exon | chr6:74176248-74183245 | chr6:73466525-73473522 | 82 nt | 0.4878 |
| hsa_MTO1_0001500 | Intron-Intron | chr6:74179636-74180024 | chr6:73469913-73470301 | 389 nt | 0.4216 |
| hsa_MTO1_0001700 | Intron-Exon-Intron | chr6:74181183-74183377 | chr6:73471460-73473654 | 388 nt | 0.4871 |
| hsa_MTO1_0001800 | Intron-Exon | chr6:74181183-74189849 | chr6:73471460-73480126 | 113 nt | 0.4425 |
A review consolidating existing research indicates that the circMTO1 functions as a tumor suppressor in hepatocellular carcinoma [Lee et al. DOI:10.1016/j.biopha.2018.12.052] and sponges miR-630 to reverse temozolomide chemoresistance in glioblastoma [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].